These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy. Pérez-Herrero E; Fernández-Medarde A Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885 [TBL] [Abstract][Full Text] [Related]
6. Advances in Sub-Micron Particle Based Aerosol Strategies for Efficient Systemic Delivery of Therapeutic Agents. Joshi N; Kaur S; Banerjee R Curr Pharm Des; 2016; 22(17):2470-80. PubMed ID: 26915832 [TBL] [Abstract][Full Text] [Related]
7. Nanomedicine for cancer: lipid-based nanostructures for drug delivery and monitoring. Namiki Y; Fuchigami T; Tada N; Kawamura R; Matsunuma S; Kitamoto Y; Nakagawa M Acc Chem Res; 2011 Oct; 44(10):1080-93. PubMed ID: 21786832 [TBL] [Abstract][Full Text] [Related]
8. Nanostructured lipid carriers, solid lipid nanoparticles, and polymeric nanoparticles: which kind of drug delivery system is better for glioblastoma chemotherapy? Qu J; Zhang L; Chen Z; Mao G; Gao Z; Lai X; Zhu X; Zhu J Drug Deliv; 2016 Nov; 23(9):3408-3416. PubMed ID: 27181462 [TBL] [Abstract][Full Text] [Related]
9. Nanoparticles as carriers for nasal vaccine delivery. Köping-Höggård M; Sánchez A; Alonso MJ Expert Rev Vaccines; 2005 Apr; 4(2):185-96. PubMed ID: 15889992 [TBL] [Abstract][Full Text] [Related]
10. Vincristine and temozolomide combined chemotherapy for the treatment of glioma: a comparison of solid lipid nanoparticles and nanostructured lipid carriers for dual drugs delivery. Wu M; Fan Y; Lv S; Xiao B; Ye M; Zhu X Drug Deliv; 2016 Oct; 23(8):2720-2725. PubMed ID: 26203691 [TBL] [Abstract][Full Text] [Related]
11. Nanocarriers Based Anticancer Drugs: Current Scenario and Future Perceptions. Raj R; Mongia P; Kumar Sahu S; Ram A Curr Drug Targets; 2016; 17(2):206-28. PubMed ID: 26201484 [TBL] [Abstract][Full Text] [Related]
12. Clinical advances of nanocarrier-based cancer therapy and diagnostics. Luque-Michel E; Imbuluzqueta E; Sebastián V; Blanco-Prieto MJ Expert Opin Drug Deliv; 2017 Jan; 14(1):75-92. PubMed ID: 27339650 [TBL] [Abstract][Full Text] [Related]
13. Insights on Oral Drug Delivery of Lipid Nanocarriers: a Win-Win Solution for Augmenting Bioavailability of Antiretroviral Drugs. Nabi B; Rehman S; Baboota S; Ali J AAPS PharmSciTech; 2019 Jan; 20(2):60. PubMed ID: 30623263 [TBL] [Abstract][Full Text] [Related]
14. [Nanoscale drug carriers for traditional Chinese medicine research and development]. Yi CX; Yu JN; Xu XM Zhongguo Zhong Yao Za Zhi; 2008 Aug; 33(16):1936-40. PubMed ID: 19086622 [TBL] [Abstract][Full Text] [Related]
15. Polymeric vesicles: from drug carriers to nanoreactors and artificial organelles. Tanner P; Baumann P; Enea R; Onaca O; Palivan C; Meier W Acc Chem Res; 2011 Oct; 44(10):1039-49. PubMed ID: 21608994 [TBL] [Abstract][Full Text] [Related]
16. Nanocarriers for cancer-targeted drug delivery. Kumari P; Ghosh B; Biswas S J Drug Target; 2016; 24(3):179-91. PubMed ID: 26061298 [TBL] [Abstract][Full Text] [Related]
17. A new generation of polymer nanoparticles for drug delivery. Chauvierre C; Vauthier C; Labarre D; Couvreur P; Marden MC; Leclerc L Cell Mol Biol (Noisy-le-grand); 2004 May; 50(3):233-9. PubMed ID: 15209344 [TBL] [Abstract][Full Text] [Related]